2020
DOI: 10.1002/hed.26445
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic effects of combined treatment with ultrasound‐mediated cisplatin‐loaded microbubbles and atorvastatin on head and neck cancer

Abstract: Background: Previously, we used ultrasound (US)-mediated cisplatin (CDDP)-loaded microbubbles (CDDP-MBs) to increase intratumoral CDDP level while decreasing systemic cytotoxicity. Statins have shown antitumorigenic properties. Our study investigated the effects of atorvastatin with CDDP-MBs and US on head neck cancer. Methods: Cell viability analysis with CDDP-MBs and atorvastatin combined with US in FaDu cell line were tested. Cell proliferation and glutathione level were also evaluated. Results: Both CDDP a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 58 publications
(114 reference statements)
0
1
0
Order By: Relevance
“…Ultrasound -guided delivery of cisplatin-loaded microbubbles was effective in HNSCC with reduced systemic cytotoxicity and the same microbubbles loaded with both cisplatin and statins (atorvastatin) acted synergistically inhibitory towards HNSCC progression. These inhibitory anticancer effects were achieved by inducing cancer cell apoptosis that reduced tumour viability with a concurrent decrease in cellular glutathione [ 183 ]. An evaluation of cisplatin efficacy in the head and neck carcinoma-mimicking cell lines (FaDu and PE/CA-PJ49) combined with resveratrol (shown to reduce cisplatin toxicity and increase cell viability in normal HaCaT cells) revealed the induction of apoptosis in FaDu cells.…”
Section: Recent Advances In Cisplatin-associated Head and Neck Cancermentioning
confidence: 99%
“…Ultrasound -guided delivery of cisplatin-loaded microbubbles was effective in HNSCC with reduced systemic cytotoxicity and the same microbubbles loaded with both cisplatin and statins (atorvastatin) acted synergistically inhibitory towards HNSCC progression. These inhibitory anticancer effects were achieved by inducing cancer cell apoptosis that reduced tumour viability with a concurrent decrease in cellular glutathione [ 183 ]. An evaluation of cisplatin efficacy in the head and neck carcinoma-mimicking cell lines (FaDu and PE/CA-PJ49) combined with resveratrol (shown to reduce cisplatin toxicity and increase cell viability in normal HaCaT cells) revealed the induction of apoptosis in FaDu cells.…”
Section: Recent Advances In Cisplatin-associated Head and Neck Cancermentioning
confidence: 99%